Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KDM4E | B2RXH2 | 8/20 | 0.71 |
| ▸ | ALDH1A1 | P00352 | 7/20 | 0.71 |
| ▸ | MAPT | P10636 | 6/20 | 0.71 |
| ▸ | LMNA | P02545 | 4/20 | 0.71 |
| ▸ | GAA | P10253 | 2/20 | 0.65 |
| ▸ | MAT2A | P31153 | 1/20 | 0.65 |
| ▸ | SMN1; SMN2 | Q16637 | 3/20 | 0.63 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.61 |
| ▸ | TP53 | P04637 | 2/20 | 0.61 |
| ▸ | OPRK1 | P41145 | 1/20 | 0.61 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.61 |
| ▸ | POLB | P06746 | 1/20 | 0.58 |
| ▸ | RAD52 | P43351 | 1/20 | 0.58 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.57 |
| ▸ | NPSR1 | Q6W5P4 | 3/20 | 0.56 |
| ▸ | HPGD | P15428 | 2/20 | 0.56 |
| ▸ | USP2 | O75604 | 1/20 | 0.56 |
| ▸ | CASP1 | P29466 | 1/20 | 0.56 |
| ▸ | CASP7 | P55210 | 1/20 | 0.56 |
| ▸ | ADORA1 | P30542 | 1/20 | 0.56 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL19639039 | 0.86 | KDM4E (0.71) | KDM4EALDH1A1MAPTLMNAGAA | |
| SCHEMBL17367223 | 0.86 | KDM4E (0.71) | KDM4EALDH1A1MAPTLMNAGAA | |
| SCHEMBL29992999 | 0.86 | KDM4E (0.71) | KDM4EALDH1A1MAPTLMNAGAA | |
| SCHEMBL13585302 | 0.84 | MAPK1 (0.65) | KDM4EALDH1A1MAPTLMNAGAA | |
| SCHEMBL24108921 | 0.83 | MAPT (0.61) | KDM4EALDH1A1MAPTLMNAGAA | |
| SCHEMBL13440492 | 0.83 | KDM4E (1.00) | KDM4EALDH1A1MAPTLMNAGAA | |
| SCHEMBL8925803 | 0.83 | HSP90AB1 (0.75) | KDM4EALDH1A1MAPTLMNAGAA | |
| SCHEMBL11015151 | 0.81 | KDM4E (0.51) | KDM4EALDH1A1MAPTLMNAGAA | |
| SCHEMBL808420 | 0.81 | KDM4E (0.77) | KDM4EALDH1A1MAPTLMNAGAA | |
| SCHEMBL24108924 | 0.80 | KDM4E (0.61) | KDM4EALDH1A1MAPTLMNAGAA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 17 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-0079810-B1 | DERIVATIVES OF 4-PHENYL-QUINAZOLINE ACTIVE ON THE CENTRAL NERVOUS SYSTEM | SANOFI S.A. (FR) | 1986-01-22 | — | — | EP | claimed |
| US-20230257359-A1 | 4-ARYLQUINAZOLINE DERIVATIVES AS METHIONINE ADENOSYLTRANSFERASE 2A INHIBITORS | IDEAYA BIOSCIENCES, INC. | 2023-08-17 | — | — | US | disclosed |
| US-20230257359-A1 | 4-ARYLQUINAZOLINE DERIVATIVES AS METHIONINE ADENOSYLTRANSFERASE 2A INHIBITORS | IDEAYA BIOSCIENCES, INC. | 2023-08-17 | — | — | US | disclosed |
| US-20230257359-A1 | 4-ARYLQUINAZOLINE DERIVATIVES AS METHIONINE ADENOSYLTRANSFERASE 2A INHIBITORS | IDEAYA BIOSCIENCES, INC. | 2023-08-17 | — | — | US | disclosed |
| WO-2021252680-A1 | 4-ARYLQUINAZOLINE DERIVATIVES AS METHIONINE ADENOSYLTRANSFERASE 2A INHIBITORS | IDEAYA BIOSCIENCES, INC. (US) | 2021-12-16 | — | — | WO | disclosed |
| WO-2021252680-A1 | 4-ARYLQUINAZOLINE DERIVATIVES AS METHIONINE ADENOSYLTRANSFERASE 2A INHIBITORS | IDEAYA BIOSCIENCES, INC. (US) | 2021-12-16 | — | — | WO | disclosed |
| US-10032991-B2 | Compound, organic electroluminescence element material, ink composition, organic electroluminescence element, electronic device, and method for producing compound | IDEMITSU KOSAN CO., LTD. (JP) | 2018-07-24 | — | — | US | disclosed |
| US-10032991-B2 | Compound, organic electroluminescence element material, ink composition, organic electroluminescence element, electronic device, and method for producing compound | IDEMITSU KOSAN CO., LTD. (JP) | 2018-07-24 | — | — | US | disclosed |
| US-20160197288-A1 | COMPOUND, ORGANIC ELECTROLUMINESCENCE ELEMENT MATERIAL, INK COMPOSITION, ORGANIC ELECTROLUMINESCENCE ELEMENT, ELECTRONIC DEVICE, AND METHOD FOR PRODUCING COMPOUND | IDEMITSU KOSAN CO., LTD. (JP) | 2016-07-07 | — | — | US | disclosed |
| US-20160197288-A1 | COMPOUND, ORGANIC ELECTROLUMINESCENCE ELEMENT MATERIAL, INK COMPOSITION, ORGANIC ELECTROLUMINESCENCE ELEMENT, ELECTRONIC DEVICE, AND METHOD FOR PRODUCING COMPOUND | IDEMITSU KOSAN CO., LTD. (JP) | 2016-07-07 | — | — | US | disclosed |
| EP-2100507-B1 | QUINAZOLINE DERIVATIVES CAPABLE OF INHIBITING CYTOKININ SIGNALING | SUMITOMO CHEMICAL CO (JP) | 2015-02-25 | — | — | EP | disclosed |
| US-8722580-B2 | Agent for inhibiting cytokinin signaling | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2014-05-13 | — | — | US | disclosed |
| US-20100056377-A1 | AGENT FOR INHIBITING CYTOKININ SIGNALING | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2010-03-04 | — | — | US | disclosed |
| EP-2100507-A1 | SUBSTANCE CAPABLE OF INHIBITING CYTOKININ SIGNALING | Sumitomo Chemical Company, Limited (JP) | 2009-09-16 | — | — | EP | disclosed |
| US-4499092-A | ANTIEPILEPTIC AGENTS | SANOFI (FR) | 1985-02-12 | — | — | US | disclosed |
| US-4183932-A | Fused quinazolinones and preparation thereof | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 1980-01-15 | — | — | US | disclosed |
| US-4002755-A | Triazoloquinazolines | SUMITOMO CHEMICAL COMPANY, LIMITED (JA) | 1977-01-11 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20160197288-A1 | COMPOUND, ORGANIC ELECTROLUMINESCENCE ELEMENT MATERIAL, INK COMPOSITION, ORGANIC ELECTROLUMINESCENCE ELEMENT, ELECTRONIC DEVICE, AND METHOD FOR PRODUCING COMPOUND | LEF1, L1CAM, OLA1 | KDM4E 2220/4885ALDH1A1 66/4885MAPT 2940/4885 |
| US-20230257359-A1 | 4-ARYLQUINAZOLINE DERIVATIVES AS METHIONINE ADENOSYLTRANSFERASE 2A INHIBITORS | MAT2A, MAT2B, MAT1A | KDM4E 811/4885ALDH1A1 667/4885MAPT 1638/4885 |
| US-20100056377-A1 | AGENT FOR INHIBITING CYTOKININ SIGNALING | CROCC, STAT3, GRK6 | KDM4E 4572/4885ALDH1A1 2316/4885MAPT 4826/4885 |
| US-10032991-B2 | Compound, organic electroluminescence element material, ink composition, organic electroluminescence element, electronic device, and method for producing compound | LEF1, L1CAM, OLA1 | KDM4E 2220/4885ALDH1A1 66/4885MAPT 2940/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.